Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShort-Term Debt issuances
Ratios

Aytu Biopharma (AYTU) Leases: 2019-2025

Historic Leases for Aytu Biopharma (AYTU) over the last 6 years, with Sep 2025 value amounting to $1.0 million.

  • Aytu Biopharma's Leases fell 17.55% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year decrease of 17.55%. This contributed to the annual value of $1.1 million for FY2025, which is 27.99% up from last year.
  • Per Aytu Biopharma's latest filing, its Leases stood at $1.0 million for Q3 2025, which was down 4.81% from $1.1 million recorded in Q2 2025.
  • In the past 5 years, Aytu Biopharma's Leases ranged from a high of $3.8 million in Q4 2021 and a low of $700,000 during Q3 2023.
  • Moreover, its 3-year median value for Leases was $1.2 million (2024), whereas its average is $1.4 million.
  • In the last 5 years, Aytu Biopharma's Leases soared by 1,138.41% in 2021 and then tumbled by 76.48% in 2023.
  • Over the past 5 years, Aytu Biopharma's Leases (Quarterly) stood at $3.8 million in 2021, then slumped by 30.43% to $2.7 million in 2022, then decreased by 20.26% to $2.1 million in 2023, then plummeted by 44.77% to $1.2 million in 2024, then fell by 17.55% to $1.0 million in 2025.
  • Its Leases was $1.0 million in Q3 2025, compared to $1.1 million in Q2 2025 and $1.1 million in Q1 2025.